Fund to provide emergency financial support for Delaware cancer
patients and their families
WILMINGTON, Del.--(BUSINESS WIRE)--Oct. 6, 2017--
Incyte Corporation (Nasdaq:INCY) and Cancer Support Community Delaware
(CSCDE) today announced the establishment of the Incyte Cancer Care
Assistance Fund for Delaware which will provide emergency financial
assistance for cancer patients, their caregivers and family members
living in Delaware.
This press release features multimedia. View the full release here:
Through the Incyte Charitable Giving Foundation, Incyte has committed to
providing a maximum of $100,000 each year to CSCDE over the next 5
years, beginning in 2018.
“We are very pleased to announce the creation of the Incyte Cancer Care
Assistance Fund for Delaware with Cancer Support Community Delaware, an
organization which, like Incyte, is dedicated to supporting patients
with cancer and the local community,” said Paula Swain, Executive Vice
President of Human Resources and Chair of The Incyte Charitable Giving
Foundation. “Today, as we celebrate the opening of our newly expanded
headquarters in Wilmington, we reaffirm our commitment to Delaware and
to the well-being of the communities we serve.”
The fund will be administered by Cancer Support Community Delaware.
Additional details about the Incyte Cancer Care Assistance Fund for
Delaware will be made available in January 2018.
“Through the establishment of this fund, we aim to address the emergent
needs that patients with cancer in Delaware face as they navigate their
disease and its impact across all aspects of their lives,” said Nicole
Topkis Pickles, Executive Director of Cancer Support Community Delaware.
About Cancer Support Community Delaware
The mission of Cancer Support Community Delaware is to ensure that all
people impacted by cancer are empowered by knowledge, strengthened by
action and sustained by community. Through participation in
professionally led support groups, educational workshops and mind/body
classes, people affected by cancer learn vital skills that enable them
to regain control, reduce isolation and restore hope regardless of the
stage of disease. At Cancer Support Community Delaware, all programs are
at no cost to cancer patients, caregivers and family members. More
information about Cancer Support Community Delaware is available at www.cancersupportdelaware.org.
About the Incyte Charitable Giving Foundation
The Incyte Charitable Giving Foundation, part of Incyte Involved, the
Company’s philanthropic and employee and community engagement program,
provides charitable donations to publicly funded 501(c) (3) tax-exempt
nonprofit organizations specifically serving the needs of communities in
Delaware focused on two areas—Oncology Patient Support and Resources and
More information regarding Incyte Involved and the Incyte Charitable
Giving Foundation, including the application process, funding
guidelines, important information for applicants and quarterly
submissions calendar, can be found here.
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical
company focused on the discovery, development and commercialization of
proprietary therapeutics. For additional information on Incyte, please
visit the Company’s
website. Follow @Incyte on Twitter.
Except for the historical information set forth herein, the matters set
forth in this press release, including statements regarding the
expectations for, and the focus of, the Incyte Charitable Giving
Foundation, contain predictions, estimates and other forward-looking
statements. These forward-looking statements are based on the Company’s
current expectations and subject to risks and uncertainties that may
cause actual results to differ materially, including, without limitation
those risks detailed from time to time in the Incyte’s reports filed
with the Securities and Exchange Commission, including its Form 10-Q for
the quarter ended June 30, 2017. Incyte disclaims any intent or
obligation to update these forward-looking statements.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171006005108/en/
Source: Incyte Corporation and Cancer Support Community Delaware (CSCDE)
Catalina Loveman, +1
Booth, DPhil, +1 302-498-5914